Viracta Therapeutics, Inc.
Pharmaceutical company · Cardiff, California, United States
Viracta Therapeutics, Inc. is a pharmaceutical company headquartered in Cardiff, California, United States. It has received 11 US government small-business research awards (SBIR/STTR) from health agencies, $5 million in total, most recently in 2004. It has reported private securities offerings to the US SEC, most recently $29 million sold in a notice filed in 2010.
Viracta Therapeutics at a glance
What does Viracta Therapeutics do?
US government research funding
11 SBIR/STTR small-business research awards from US health agencies, $5 million in total (1999 to 2004).
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $28.5 million sold (2010).
Frequently asked questions about Viracta Therapeutics
Where is Viracta Therapeutics headquartered?
Viracta Therapeutics, Inc. is headquartered in Cardiff, California, United States.
What does Viracta Therapeutics do?
Viracta Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.